(Q72919105)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6275456%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Evidence for a dual action of converting enzyme inhibitor on blood pressure in normal man (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6275456%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Evidence from a dual action of converting enzyme inhibitor on blood pressure in normal man (English)

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

14 September 2023

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

14 September 2023

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

14 September 2023

author name string

R. Goldstone

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6275456

14 September 2023

K. Martin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6275456

14 September 2023

R. Zipser

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6275456

14 September 2023

R. Horton

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6275456

14 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6275456

14 September 2023

publication date

1 October 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6275456%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

30 October 2019

https://api.elsevier.com/content/article/PII:009069808190068X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

https://api.elsevier.com/content/article/PII:009069808190068X?httpAccept=text/plain

14 September 2023

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

14 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6275456%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6275456%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6275456%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

587-598

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6275456%20AND%20SRC:MED&resulttype=core&format=json

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

30 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Accentuated Vascular and Endocrine Response to Sq 20881 in Hypertension

14 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

14 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Role of prostaglandin in the antihypertensive mechanism of captopril in low renin hypertension

14 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation

14 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Converting enzyme inhibition with an orally active compound in hypertensive man

14 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Some properties of angiotensin converting enzyme in the lung in vivo

14 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects

14 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

A radioimmunoassay for aldosterone in human peripheral plasma including a comparison of alternate techniques

14 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Impaired renal production of prostaglandin E2: A newly identified lesion in human essential hypertension

14 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Effect of prostaglandin inhibition on the hypertensive action of sodium-retaining steroids

14 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Accentuated Vascular and Endocrine Response to Sq 20881 in Hypertension

14 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension

14 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man

14 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

The effects of kininase II inhibition by SQ 14225 on kidney kallikrein-kinin and prostaglandin systems in conscious dogs

14 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Implication of endogenous prostaglandin system in the antihypertensive effect of captopril, SQ 14225, in low renin hypertension

14 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man

14 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension

14 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Chemical instability of 15-keto-13,14-dihydro-PGE2: the reason for low assay reliability

14 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls

14 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Prostacyclin mediates the potentiated hypotensive effect of bradykinin following captopril treatment

14 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Mechanism of action of antiotensin II and antidiuretic hormone on renin secretion

14 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

Calcium dependence of the inhibitory effect of angiotensin on renin secretion in the isolated perfused kidney of the rat

14 September 2023

35

1 reference

https://api.crossref.org/works/10.1016/0090-6980(81)90068-X

14 September 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6275456%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1 reference